Crossmark

A bioinformatics approach combined with experimental validation analyzes the efficacy of azithromycin in treating SARS-CoV-2 infection in patients with IPF and COPD

Crossref DOI link: https://doi.org/10.1038/s41598-025-94801-9

Published Online: 2025-03-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xie, Yining

Chen, Guangshu

Wu, Weiling

Wen, Xueman

Lai, Meizheng

Che, Li

Ran, Jianmin
Funding

Funding for this research was provided by:

Zhongnanshan Medical Foundation of Guangdong Province (ZNSJJH-XS-[2022]-[06]-[004])
License Information

Text and Data Mining valid from 2025-03-23

Version of Record valid from 2025-03-23
More Information

Article History

Received: 5 December 2024

Accepted: 17 March 2025

First Online: 23 March 2025

Declarations

:

: The authors declare no competing interests.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below